APPLICATION
ANDA074141
TYPE
ANDA
ORIGINAL APPROVAL
1995-01-31
LATEST ACTION
2024-08-23
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
METOPROLOL TARTRATEDiscontinued
METOPROLOL TARTRATE 100MG · TABLET · ORAL
METOPROLOL TARTRATEDiscontinued
METOPROLOL TARTRATE 50MG · TABLET · ORAL
Approval history
2024-08-23Labeling · Supplement 37 · standardAP
2015-07-31Labeling · Supplement 35 · standardAP
2013-03-18Labeling · Supplement 34AP
2010-03-30Labeling · Supplement 32AP
2010-03-11Labeling · Supplement 33AP
2002-03-26Manufacturing (CMC) · Supplement 22AP
2002-01-22Manufacturing (CMC) · Supplement 21AP
2001-02-02Manufacturing (CMC) · Supplement 20AP
2000-04-18Manufacturing (CMC) · Supplement 19AP
1999-12-02Manufacturing (CMC) · Supplement 16AP
1999-12-02Manufacturing (CMC) · Supplement 17AP
1999-11-02Labeling · Supplement 18AP
1999-02-12Manufacturing (CMC) · Supplement 9AP
1999-02-12Manufacturing (CMC) · Supplement 8AP
1998-10-07Manufacturing (CMC) · Supplement 7AP
1998-01-29Manufacturing (CMC) · Supplement 6AP
1997-05-19Manufacturing (CMC) · Supplement 5AP
1997-01-14Manufacturing (CMC) · Supplement 3AP
1996-08-16Manufacturing (CMC) · Supplement 2AP
1996-06-18Manufacturing (CMC) · Supplement 1AP
1995-01-31OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.